| Filed On | Filing |
|---|---|
| 03 Jun 2026 |
8-K/A: Financial Statements and Exhibits
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UN... |
| 02 Jun 2026 |
8-K/A: Financial Statements and Exhibits
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATI... |
| 04 May 2026 |
8-K/A: Entry into a Material Definitive Agreement
The disclosure set forth in Item 1.01 of the Original Report is hereby amended and restated in its entirety as follows: |
| 21 Apr 2026 |
8-K/A: Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Listing Rule +2 more
This Collaboration Agreement (this “Agreement”), dated Effective April 13, 2026, is entered into between Kare Rx Hub, LLC, a Florida limited liability company (“Kare Hub”) its parent Kare Pharmtech, LLC, a Florida limited liability compa... |
| 26 Nov 2025 |
8-K/A: Entry into a Material Definitive Agreement; Regulation FD Disclosure
Datavault AI Licenses Patents Covering Digital Ledger-enabled Smart Contracts for Commercial Prescription Drug Distribution Industry to Wellgistics Health |
Loading...
